Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Erica Rojas Bilbao is active.

Publication


Featured researches published by Erica Rojas Bilbao.


Arquivos Brasileiros De Endocrinologia E Metabologia | 2013

Soft tissue metastases from differentiated thyroid cancer diagnosed by 18F FDG PET-CT

Inés Califano; Sergio Quildrian; Martín Coduti; Erica Rojas Bilbao; José Otero; Leonardo L Califano

Distant metastases of differentiated thyroid cancer are unusual; lung and bones are the most frequently affected sites. Soft tissue metastases (STM) are extremely rare. We describe two cases of patients with differentiated thyroid cancer metastasizing to soft tissues. Both patients had widespread metastatic disease; clinically asymptomatic soft tissue metastases were found by ¹⁸-Fluordeoxyglucose positron emission tomography/computed tomography (¹⁸F FDG PET-CT), and confirmed by cytological and/or histopathological studies. These findings underscore the ability of ¹⁸F FDG PET-CT in accurately assessing the extent of the disease, as well as the utility of the method to evaluate regions of the body that are not routinely explored.


Rare Tumors | 2013

Primary NK/T cell lymphoma nasal type of the colon

Carolina Valeria Mahuad; Erica Rojas Bilbao; Gonzalo Garate; María de los Ángeles Vicente Repáraz; Mercedes del Olmo; Claudia Casali; Marta E. Zerga; Ana María Chirife; Juan Cicco

Since nasal NK/T-cell lymphoma and NK/T-cell lymphoma nasal type are rare diseases, colonic involvement has seldom been seen. We report a case of a patient with a primary NK/T-cell lymphoma nasal type of the colon. The patient had no history of malignant diseases and was diagnosed after exhaustive study in the context of fever of unknown origin. The first therapeutic approach followed the DA-EPOCH-protocol: etoposide, prednisone, doxor-rubicin, vincristine and cyclophosphamide. The persistence of constitutional symptoms after the first treatment course motivated the switch to a second line following the SMILE-protocol: dexamethasone, metotrexate, ifosfamide, E.coli L-asparaginase, and etoposide. Despite intensive chemotherapy, the patient died 2 months after the diagnose of an extranodal NK/T-cell lymphoma of the colon and 4 months after the first symptomatic appearance of disease.


Neurología Argentina | 2010

Estudio de una cohorte de pacientes adultos con tumores primarios de sistema nervioso central de la serie glial

Juan Martín Cardozo Oliver; Alejandra Báez; Mariana Báez; Erica Rojas Bilbao; Valeria Kuchkaryan; Ignacio Casas Parera

Resumen Introduccion En los ultimos anos se sucedieron cambios en la neurooncologia que mejoraron la calidad de vida y sobrevida de pacientes con tumores primarios (TP) del SNC. Objetivos Presentar las caracteristicas clinicas de una cohorte de pacientes con TP de SNC de la serie glial. Material y metodos Entre los anos 2002-2009 se realizo el seguimiento de 148 pacientes con TP de SNC. Se analizaron solo los tumores de la serie glial intracraneanos. Este es un estudio descriptivo. Resultados Setenta y nueve pacientes (52 varones y 27 mujeres) presentaron tumores de la serie glial. El mayor numero de casos se presentaron en la cuarta decada. Segun la histopatologia: 34 glioblastomas multiformes (GBM), 6 astrocitomas GIII, 9 astrocitomas GII, 5 astrocitomas GI, 3 gliomas de tronco, 1 glioma cordoide, 16 oligodendrogliomas GII y 5 oligodendrogliomas GIII. La localizacion mas frecuente fue en el lobulo frontal. Los sintomas de inicio, en orden de frecuencia, fueron: crisis comiciales, cefalea, afasias, deficits cognitivos, motores o sensitivos, patologia de pares y sindrome de hipertension endocraneana. En 27 pacientes el tratamiento fue quirurgico/radioterapia/quimioterapia (Qx/Rt/Qt), 20 Rt/Qt, 6 Qx, 6 Qt, 5 Rt, 5 Qx/Qt, 4 Qx/Rt, y 6 pacientes no realizaron tratamiento. El 51% de los pacientes tuvieron reseccion parcial o completa del tumor. Las crisis epilepticas (parciales [62%] y generalizadas [38%]) fueron controladas completamente en el 66% de los casos con monoterapia. Conclusiones El GBM fue el tumor mas frecuente y el lobulo frontal el mas comprometido. El sintoma prevalente fueron las crisis epilepticas. Obtuvimos un porcentaje bajo de pacientes con reseccion parcial o completa del tumor.


Medicina-buenos Aires | 2008

Neoplasia hematodérmica CD4+ CD56+ en la infancia

Erica Rojas Bilbao; Ana María Chirife; Darío Llorio; Lliliana B. Giménez; Lina Marino; Diego Rosso


Medicina-buenos Aires | 2010

Linfomas de la órbita y anexos oculares: Correlación clínico patológica de 25 casos

Erica Rojas Bilbao; Martina Nesprias; Carla Pulero; Liliana Giménez; Marta E. Zerga; Ana María Chirife


Medicina-buenos Aires | 2004

Linfoma de células en anillo de sello que simula carcinoma mucosecretante

Ana María Chirife; Erica Rojas Bilbao; Liliana Giménez; Lina Marino; Francisco Celeste


Journal of Thoracic Oncology | 2017

P1.02-010 Frequency of Uncommon EGFR Mutations in NSCLC in an Argentinean University Institution: Topic: Driver Genes in NSCLC, Resistance, and Other

C. Gabay; Martin A. Krasnapolski; Maria Nazareth Rusjan; Liliana Giménez; Erica Rojas Bilbao; Luis Thompson; Monica Castro


Cancer Research | 2015

Abstract 3550: Expression of Oct-2, OCA-B, BCL6, PU.1 and IRF8 predicts prognosis in Diffuse Large B Cell Lymphoma patients

Erica Rojas Bilbao; Elisa Bal de Kier Joffé; Marta E. Zerga; Lydia Puricelli; Stella M. Ranuncolo


Revista Española de Patología | 2014

Estudio fenotípico de inestabilidad microsatelital en cáncer colorrectal. Correlación con parámetros histológicos y clínicos

Lilia Schmitz; Lucas Moretti; Lina Marino; Liliana Giménez; Erica Rojas Bilbao


Revista Argentina de Urología | 2014

La expresión de S100A9, vinculada con el óxidonítrico, es un marcador de mal pronóstico enpacientes con cáncer de vejiga, siendo su inhibiciónun posible blanco terapéutico

Yanina Langle; Eduardo Sandes; Denise Belgorosky; Natalia Balarino; Bárbara Prack Mc Cormick; Lina Marino; Erica Rojas Bilbao; Leonardo Pasik; H. Malagrino; Alberto Casabé; Ana María Eiján

Collaboration


Dive into the Erica Rojas Bilbao's collaboration.

Top Co-Authors

Avatar

Lina Marino

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Liliana Giménez

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Marta E. Zerga

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Alejandra Báez

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Ana María Eiján

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Denise Belgorosky

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

Eduardo Sandes

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

H. Malagrino

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Inés Califano

University of Buenos Aires

View shared research outputs
Researchain Logo
Decentralizing Knowledge